key: cord-0736018-12i28ynv authors: Lai, Alessia; Bergna, Annalisa; Menzo, Stefano; Zehender, Gianguglielmo; Caucci, Sara; Ghisetti, Valeria; Rizzo, Francesca; Maggi, Fabrizio; Cerutti, Francesco; Giurato, Giorgio; Weisz, Alessandro; Turchi, Chiara; Bruzzone, Bianca; Ceccherini Silberstein, Francesca; Clementi, Nicola; Callegaro, Annapaola; Sagradi, Fabio; Francisci, Daniela; Venanzi Rullo, Emmanuele; Vicenti, Ilaria; Clementi, Massimo; Galli, Massimo title: Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 date: 2021-08-14 journal: Virol J DOI: 10.1186/s12985-021-01638-5 sha: ddd84761c0f6a59dac82f97734daf929694a9043 doc_id: 736018 cord_uid: 12i28ynv A growing number of emerging SARS-CoV-2 variants is being identified worldwide, potentially impacting the effectiveness of current vaccines. We report the data obtained in several Italian regions involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021. Starting from April 2020 when the Cluster 5 [1] variant was first described, multiple SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) variants have emerged in different parts of the world. The Alpha variant (formerly known as B.1.1.7) was first identified in the UK from a sample obtained in late September 2020 [2, 3] (https:// www. who. int/ en/ activ ities/ track ing-SARS-CoV-2-varia nts/#: ~: text= Naming% 20SARS% 2DCoV% 2D2% 20var iants ,scien tists% 20and% 20in% 20sci entif ic% 20res earch), Beta variant (B.1.351) was identified in October 2020 in South Africa [4] , and Gamma variant (P.1) was identified in Brazil in December 2020 [5] . These variant strains show multiple changes (deletions and substitutions) in the spike protein (9 in B.1.1.7, 10 in B.1.351, and 12 in P.1) compared with the reference genome Wuhan-Hu-1 sequence (EPI_ISL_406800), some of which affect the receptor-binding domain (RBD) region. The major issue with these variants is their potential to outcompete and rapidly replace formerly prevalent lineages, first in the areas where they likely emerged and subsequently spread in many other countries [6] [7] [8] . Increased SARS-CoV-2 diversity raises the concern of escape from preexisting immunity, elicited either by previous infection or by vaccination. Here, we report data from several Italian centers located in Campania, Lazio, Lombardy, Liguria, Marche, Piedmont, Tuscany, Sicily and Umbria, involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021. Globally, we analysed data from 3744 samples obtained by different techniques: RT-PCR variant screening assays (n = 2095), spike Sanger or Next Generation Sequencing (n = 649) and Whole Genome Sequencing (WGS; n = 1000) ( Table 1) . Data for the analyses were obtained from each center as a part of routine test of variant monitoring or for research purpose for those not involved in national surveillance but included in the SCIRE (SARS-CoV-2 Italian Research Enterprise) collaborative group. The table shows the analyzed data stratified according to different methodologies used for the variant monitoring and months of sampling collection. The number of samples considered for variant monitoring increased from 4.2% (158/3744) in October to 32% (1215/3744) in March, due to the increasing interest in viral variants at global level. In the study period, the Alpha variant (B.1.1.7) significantly increased, growing from 3.5% (6/173) in December, to 86.7% (1054/1215) in March (p < 0.001). Particularly, from the second half of December this lineage was already present in Liguria (n = 1 on the 18th), Campania (n = 3, on the 28th) and Marche (n = 2, on the 31st) (EPI_ ISL_778869, EPI_ISL_778868), with only one known case related to return from UK. The most important increase in its prevalence was observed from the second week of January (20/126, 16.0%) to the end of the same month (35/68, 51.5%) reaching 73.7% (171/232) at the end of February. In parallel, the prevalence of previously circulating variants significantly decreased from 100% (158/158) to 9.4% (114/1215). The Gamma variant (P.1) was first detected in the second half of January in Campania (n = 1), Lombardy (n = 1) and Umbria (n = 2), subsequently setting at around 2% in February (33/1234) and March (24/1215). Only few Beta and Eta variants (B.1.351 and B.1.525 respectively) cases were identified, never reaching 1% of the total samples analysed, being firstly detected in Liguria at the end of January and in Campania in mid-February, respectively. The B.1.258 lineage (also known as Scottish variant) was firstly observed in Campania, Marche and Piedmont in mid-October, 4 cases were reported in November in Campania (n = 2) and Piedmont (n = 2), thereafter it was only reported in Campania until February reaching a proportion of 18.5% (17/92) of total cases of other variants, including its descendant lineages (B. 1.258.3, B.1.258.14) . In half of March, two cases of the Iota variant (formally known as New York lineage B.1.526) were identified in Marche. Figure 1 shows This study provides insights into the rapid change in the prevalence of SARS-CoV-2 variants over six months in Italy. Interestingly, we observed the first entry of Alpha variant in Lombardy in late December, in line with the identification of first retrospective data in UK on 20 September [9] [10] [11] and those reported by ISS-Istituto Superiore di Sanità (https:// www. iss. it/ docum ents/ 20126/0/ 11-6-2021+ SECON DO+ BOLLE TTINO+ Varia nti+ SARS-CoV-2. pdf/ 7febf ab3-c32b-7505-cc1e-2176f c12cd f6?t= 16234 30432 808). The introduction of Alpha variant, notoriously associated to higher transmissibility compared to other variants and to an increased rate of mortality reported in some studies, corresponds to the second relevant increase of infections registered in Italy during the second epidemic wave [12] [13] [14] . In addition to known variants of concern, we documented other minor variants that could be early warnings of upcoming changes. Continuous monitoring of all variants is mandatory to comprehensively investigate and keep track of virus evolution, particularly along with expanding vaccination still based on original strains that have been largely substituted by novel variants. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England Detection of a SARS-CoV-2 variant of concern in South Africa Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus Characteristics of SARS-CoV-2 variants of concern B.1.1.7; B.1.351 or P.1: data from seven EU/EEA countries European Centre for Disease Prevention and Control. SARS-CoV-2-increased circulation of variants of concern and vaccine rollout in the EU/ EEA; 14th update-15 Emergence of SARS-CoV-2 B.1.1.7 lineage-United States Emergence and spread of SARS-CoV-2 lineages B.1.1.7 and P.1 in Italy convenient online submission • thorough peer review by experienced researchers in your field • rapid publication on acceptance • support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year • At BMC, research is always in progress. Learn more biomedcentral.com/submissions Ready to submit your research Ready to submit your research ? Choose BMC Cattelan A. The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations